Centro De Fertilidad Buenos Aires S.a.

What Centro De Fertilidad Buenos Aires S.a. does

Centro De Fertilidad Buenos Aires S.A. (doing business as Pregna) is a private reproductive medicine clinic founded in 2007 and headquartered in the Recoleta neighborhood of Buenos Aires, Argentina. The clinic delivers a comprehensive assisted reproduction service portfolio spanning IVF/ICSI, artificial insemination, oocyte donation (Ovodonar program), ROPA for same-sex couples, fertility preservation (both elective/social and oncological), advanced reproductive genetics (PGT-A via NGS, NIPT, genetic carrier screening, miscarriage tissue analysis), and complementary ART techniques such as AI-powered timelapse embryo selection, vitrification, MACS sperm selection, ERA/EMMA/ALICE endometrial diagnostics, Duostim double stimulation, and laser-assisted hatching. Diagnostic offerings are anchored by the Ovotest ovarian reserve screening product. The clinic also provides supportive services including nutritional counseling and psychology, and runs dedicated oncofertility programming as the only Argentine member of the U.S.-based Oncofertility Consortium.

The business operates a direct-to-patient clinical model from a single Recoleta site (Juncal 3490), with appointments booked via WhatsApp and phone. Revenue is generated from clinical services billed to a broad network of Argentine private health insurers and obras sociales — including OSDE, Swiss Medical, OMINT, Sancor Salud, and Hospital Británico — alongside out-of-pocket payments, with treatment pricing quoted on a per-patient basis rather than via public fee schedules. Patient acquisition combines physician referrals, insurance network inclusion, self-referral, and an active multi-channel content and social strategy (Instagram, Facebook, YouTube/Pregna TV, TikTok, patient webinars, and an extensive patient testimonial corpus). Cumulative patient count exceeds 30,000, and the clinic reports an assisted reproduction success rate of approximately 40% versus a ~30% general benchmark.

Operationally, Pregna fields a multidisciplinary medical team covering reproductive endocrinology, embryology, andrology, genetics, psychology, and nutrition, with credentials from UBA, CEMIC, Hospital Italiano, and Hospital de Clínicas, supplemented by international training (e.g., Italian Society of Reproductive Medicine fellowship in Bologna). The company remains private with no disclosed funding rounds, acquisitions, or parent company. Service geographies are limited to CABA and Gran Buenos Aires.

Name

Centro De Fertilidad Buenos Aires S.a.

Legal name

Centro De Fertilidad Buenos Aires S.A.

Website

https://pregna.com.ar

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Pregna is a Buenos Aires-based private fertility clinic founded in 2007 offering IVF/ICSI, oocyte donation, fertility preservation, advanced reproductive genetics, and AI-powered embryo selection to individual patients and couples across CABA and Gran Buenos Aires.

Ownership category

akta.pro rank

Product category

Reproductive Medicine

NAICS

Family Planning Centers (62141), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industry

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

Keywords

• Assisted reproduction services
• Fertility treatment
• In vitro fertilization
• Reproductive medicine
• Fertility preservation

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Assisted Reproductive Clinical Services: The clinic generates revenue through direct clinical services including consultations, diagnostic testing, IVF/ICSI treatments, egg preservation, genetic testing, and related medical procedures. Revenue is derived from both out-of-pocket payments and insurance/medical coverage billings across a wide network of prepagas and obras sociales.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels8 records

Core offering

Centro De Fertilidad Buenos Aires S.A., operating as Pregna, is a private fertility clinic in Buenos Aires, Argentina, delivering assisted reproductive treatments including IVF/ICSI, artificial insemination, oocyte donation (Ovodonación), ROPA for female couples, fertility preservation (elective and oncological), preimplantation genetic testing, and supportive reproductive medicine services. The clinic operates a specialized embryology laboratory, andrology services, sperm banking, and an ovarian reserve screening program (Ovotest), complemented by psychological and nutritional support for patients undergoing treatment.

Product overview

Pregna is a reproductive medicine clinic offering a comprehensive portfolio of assisted reproduction treatments and diagnostic services. The core offerings include FIV/ICSI, egg donation (Ovodonación), artificial insemination, and fertility preservation procedures. The clinic provides advanced genetic testing services including preimplantation genetic testing (PGT-A), non-invasive prenatal testing (NIPT), genetic carrier screening, and endometrial studies (ERA/EMMA/ALICE). Specialized services address male factor infertility through andrology services, sperm banking, and TESE biopsy. The clinic employs cutting-edge laboratory technologies including AI-powered timelapse embryo monitoring, vitrification for egg/embryo cryopreservation, annexin columns (MACS) for sperm selection, and laser-assisted hatching. Additional supportive services include nutritional counseling and psychological support, with an affiliated egg donation program (Ovodonar).

Differentiator

Problem solved

Functional benefit

Brands

• Ovodonar: Egg donation program operated by Pregna for women and couples with reproductive difficulties

Products and services

• Ovotest Ovarian Reserve Screening A 30-minute screening combining ultrasound and hormonal blood tests performed during early menstruation days to assess a woman's ovarian reserve and reproductive health.
• FIV/ICSI (IVF with Intracytoplasmic Sperm Injection) High-complexity assisted reproduction treatment performing in vitro fertilization combined with intracytoplasmic sperm injection for couples with infertility.
• Egg Preservation (Preservación de Óvulos) Fertility preservation through egg vitrification for women who wish to postpone motherhood for personal, social, or professional reasons.
• Ovodonación (Oocyte/Egg Donation) In vitro fertilization treatment using donated eggs from young women under 30, indicated for women with ovarian failure, diminished ovarian reserve, or genetic conditions.
• Inseminación (Artificial Insemination) Artificial insemination procedure placing pre-selected laboratory-prepared sperm into the uterus.
• ROPA Method Reception of oocytes from partner for female couples, where one partner provides the eggs and the other carries the pregnancy.
• Preimplantation Genetic Testing (PGT-A) Preimplantation genetic testing for aneuploidies analyzing embryo chromosomes via NGS sequencing before transfer to increase pregnancy chances and reduce miscarriage rates.
• Genetic Carrier Compatibility Test Genetic carrier screening test evaluating risk of having offspring with recessive genetic diseases before pregnancy.
• Non-Invasive Prenatal Test (NIPT) Non-invasive prenatal test analyzing fetal DNA in maternal blood from week 9 of pregnancy to detect chromosomal abnormalities including trisomies 21, 18, 13 and sex chromosome aneuploidies.
• Genetic Counseling (Asesoramiento Genético) Genetic counseling service providing information and guidance on genetic risks and inherited conditions for prospective and expecting parents.
• Miscarriage Tissue Genetic Test Genetic analysis of miscarriage tissue using NGS sequencing to identify chromosomal abnormalities causing pregnancy loss.
• Ovarian Tissue Cryopreservation Surgical extraction and vitrification of ovarian tissue cortex to preserve fertility before chemotherapy or radiation in oncology patients.
• Oocyte/Embryo Vitrification Ultra-rapid freezing technique (vitrification) preserving eggs and embryos at -196°C in liquid nitrogen for future use, with reported post-thaw survival rates above 90%.
• MACS Annexin Columns (Magnetic-Activated Cell Sorting) Magnetic separation technique to isolate non-apoptotic sperm from apoptotic sperm before assisted reproduction treatment, used in cases of high sperm DNA fragmentation.
• Laser-Assisted Hatching Laser-assisted hatching procedure that creates a small opening in the zona pellucida to facilitate embryo implantation.
• Embryoglue Transfer Medium Embryo transfer medium containing a high concentration of hyaluronic acid that enhances embryo adhesion to the endometrium and improves implantation rates.
• Duostim (Double Ovarian Stimulation) Two ovarian stimulations within a single menstrual cycle to maximize oocyte/embryo yield in a shorter timeframe, recommended for low ovarian reserve and oncology patients.
• Endometrial Studies (ERA, EMMA, ALICE) Endometrial receptivity analysis (ERA), endometrial microbiome evaluation (EMMA), and chronic infectious endometritis detection (ALICE) to personalize embryo transfer timing.
• Timelapse with Artificial Intelligence (AI Embryo Selection) Time-lapse incubator system with AI-powered embryo selection algorithm that continuously monitors embryo development without removing embryos from incubation conditions.
• Sperm Bank (Banco de Semen) Sperm bank offering semen cryopreservation services for oncology patients and those seeking fertility preservation.
• Andrology Services Male reproductive health services including sperm analysis, DNA fragmentation testing (TUNEL), sperm preparation for IUI/IVF/ICSI, and TESE biopsy.
• Testicular Biopsy (TESE) Testicular biopsy procedure for sperm retrieval in patients with obstructive or secretory azoospermia.
• Oncofertility Program (Oncofertilidad) Fertility preservation program for oncology patients integrated with the Oncofertility Consortium international network, offering egg vitrification before cancer treatment.
• Nutritional Counseling (Nutrición) Nutritional guidance and webinars focused on fertility-optimizing dietary habits for patients undergoing treatment.
• Psychological Support (Apoyo Psicológico) Psychological support through monthly webinars addressing emotional aspects of the fertility journey, providing guidance to women and couples.

Quantifiable outcome

• ~40% success rate in assisted reproduction treatments, compared to ~30% general average
• +2 more outcomes

Named customers15 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature10 records

Partnerships

One partnership is on record.

• Oncofertility ConsortiumflagshipStrategic or Co-development PartnerPregna is the only center in Argentina integrated into the Oncofertility Consortium, an international organization headquartered in the United States. The consortium connects professionals, patients, and researchers worldwide to address fertility preservation for cancer patients through web platforms, media, smartphone applications, and annual symposiums and congresses.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• CEGYR (Centro de Estudios en Ginecología y Reproducción): Established Buenos Aires reproductive medicine center offering IVF, ICSI, egg donation, and genetic testing. Competes for the same urban, insurance-covered patient base as Pregna in CABA.
• Fecunditas: Argentine reproductive medicine center providing IVF, ICSI, and egg donation. Comparable in clinical positioning and patient profile to Pregna, and competes in the broader Buenos Aires catchment.
• Halitus Instituto Médico: Buenos Aires-based fertility and reproductive genetics clinic. Overlaps with Pregna across IVF, donor programs, and preimplantation genetic testing, serving a similar demographic in the same metro area.
• In Vitro Buenos Aires: Specialized IVF and reproductive medicine clinic in Buenos Aires. Comparable service menu (IVF/ICSI, egg donation, fertility preservation) and competitive overlap in the local CABA market.
• PROCREARTE: One of the largest fertility clinic networks in Argentina, headquartered in Buenos Aires with multiple sites. Directly comparable to Pregna in offering IVF/ICSI, egg donation, PGT, and fertility preservation, and is explicitly named in Pregna-affiliated embryologist training history.

Broad incumbents

• IVI – Instituto Valenciano de Infertilidad (IVI-RMA): Global fertility clinic chain with Latin American presence. Provides the same core reproductive services at much greater scale, representing both a benchmark and a potential competitive threat if it expands in Argentina.

Regional players

• GENESIS Fertility & Reproductive Medicine: Multi-site reproductive medicine group in the United States offering IVF, egg donation, and oncofertility. Provides a comparable integrated specialty clinic model outside Argentina for benchmarking expansion strategy.
• Fertility Center of San Antonio / Posterity Health: US-based fertility and reproductive health services network. Operates in a different geography but offers comparable IVF, fertility preservation, and genetic testing service models relevant to a Latin American operator scaling beyond Argentina.

Emerging players

• Genea Biomedx: Fertility technology provider focused on IVF lab automation, time-lapse, and AI embryo assessment. Comparable through Pregna's adoption of AI timelapse incubators and advanced lab technologies.

Others

• CooperGenomics / Genomic Prediction: Reproductive genetics laboratory specializing in PGT-A and PGT-M testing. Comparable to Pregna's in-house PGT and NIPT genetic testing line and a likely upstream partner or competitor for embryo genetics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@pregna.medicinareproductiva
• Facebookfacebook.com/PregnaMed
• LinkedInlinkedin.com/company/pregna-medicina-reproductiva
• Instagraminstagram.com/pregna.medicinareproductiva

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centro De Fertilidad Buenos Aires S.a.